Evaluation of Hepatitis-B and Its Markers Among Some Attendees of Two Health Facilities In Port Harcourt, Rivers State, Nigeria
https://dx.doi.org/10.4314/njpar.v42i2.27
Keywords:
Hepatitis-B, assessment, HBV-markers, administration, NigeriaAbstract
A cross-sectional investigation of hepatitis-B status among attendees of Modern Primary Health Centre, Eneka and Rivers State University Teaching Hospital, Port Harcourt was evaluated. Seven hundred (700) subjects of different ages of both sexes were included in the study after ethical approval was obtained from the Rivers State Ministry of Health, Port Harcourt. Consent forms were issued to get subjects’ consent before questionnaire administration to obtain their demographic data. The uninfected subjects were used as control. About 4mls of blood was taken from each subject by vein-puncture; 2mls each was dispensed into EDTA and plain bottles for analysis. The samples were used to assay for hepatitis-B surface antigen (HBsAg), hepatitis–B virus (HBV) markers (HBsAb, HBeAg, HBeAb, HBcAb) using standard techniques. The overall prevalence of HBV was 5.1% in Port Harcourt. The males had higher prevalence of 7.9% HBV than the females 3.4% HBV, although there was no statistically significant difference (P ≥0.05). The HBV was highest among subjects of age group 24-29 years (8.29%) and 30-35 years (9.2%) accordingly. The HBV markers results show that while HBsAg occurred among all the subjects that were positive for HBV, HBeAb was completely absent.
References
World Health Organization. (2017). Global Hepatitis B Report; Fact Sheet. www.who.int/mediacentre/facts. 13th January, 2018.
Sharif, A.A., Dabo. N.T. and Getso, M.I. (2015). Prevalence of Malaria and Hepatitis B Virus Infection in Febrile Patients in Kano, Northwest Nigeria. International Journal of Current Research and Review, 7(9), 61-65.
Oyetunde, O. and Amugo, A. (2015). Plasmadium falciparum and Hepatitis B Virus Infection in Nigeria Urban Population. Brazilian Journal of Infectious Diseases, 19, (6) 243-248.
Omalu, I.C.J., Jibrin, A., Olayemi, I.K., Hassan, S.C., Mgbemena, C., Mgbemena,A. and Adeniran, L.A. (2012). Seroprevalence of Malaria and Hepatitis B.(HBsAg) with Associated Risk Factors among Pregnant Women Attending Antenatal Clinic in General Hospital Minna, North-central, Nigeria. Annual Review and Research Biology,2 (4),83-88.
Centres for Disease Control and Prevention (2019). Viral hepatitis surveillance, United States, 2017, Atlanta : US Department of Health and human services, Canters for Disease Control and Prevention, 2019.
Mueller, A., Stoetter, L and Kalluvya, S. (2015). Prevalence of Hepatitis B Virus Infection among Health Care Workers in a Tertiary Hospital in Tanzania. BioMed Central Infectious Disease, 15, 132 – 139.
Ikobah, J., Okpara, H., Elemi, I., Ogarepe, Y., Udoh, E. and Ekanem, E. (2016). The Prevalence of Hepatitis B Virus Infection in Nigeria Children Prior to Vaccine Introduction into the National Programme on Immunization Schedule. The Pan African Medical Journal, 23, 128. 8756.
Nawfal, R. H. (2018). Risk Factors of Hepatitis B Virus Infection among Blood Donors in Duhok City, Kurdistan Region, Iraq. Casplan Journal Of Internal Medicine, 9(1):22-26
World Health Organization. (2013). Hepatitis B and C, Immunization, Vaccines and Biologicals. Available from: h t t p : / / w w w . w h o . i n t / Immunization/Topics/Hepatitis/End/.
Musa, B., Bussell, S., Borodo, M.M., Samaila, A.A. and Femi, O.L. (2015). Prevalence of Hepatitis B Virus Infection in Nigeria, 2000-2013: A Systematic Review and Meta-Analysis. Niger Journal of Clinical Practice,18,163- 172.
Stevenson, M.M. and Riley, E.M. (2004). Innate Immunity to Malaria. Nature Review Immunology, 4, 169-180.
Singh, R., Musa, J., Singh, S. and Ukatu, V.E. (2014). Knowledge,Attitude and Practice on Malaria among the Rural Communities in Aliero, Northern, Nigeria. Journal of Family Medicine and Primary Care, 3(1),39-44.
Thrushfield, M. (2005). Veterinary Epidemiology (3rd Edition) UK: Oxford Black Well Science.
Ebong, O.O., Nwauche, C.A., Ogbuchi, I. H., Chijioke – Nwauche, I.N., Ezirim, C.I., Umoh, R.E., Afia, A.G. and Zarakokpa P. (2015). Is this Evidence of Success in Malaria Prevention and Control Measures? Greener Journal of Medical Sciences, 5(1), 001-010.
Lecture, M. L.(2014). Screening for hepatitis B virus infection in nonpregnant adolecents and adults: US preventive services Task Force recommendation statement. Annuals of Internal Medicine, 161(1), 58- 66.
Ejele, O.A. and Ojule,A.C. (2003). Hepatitis B A n t i g e n a e m i a ( H B s A g ) : R i s k Occupational Exposure in Chemical Pathology Laboratory in Nigeria. North American Journal of Medical Sciences, 5 (4),293-300.
Adoga, M.P., Gyar, S.D., Peculano, S., Bashayi, O.D., Emiasegen, S.E. and Zungwe, T. (2010). Hepatitis B Virus Infection in Apparently Healthy Urban Nigerians data from pre-vaccination tests. Journal of Infections Developing Countries, 4 (6), 397-400.
Kolawole, M.O., Whab, A.A., Adekule, D.A., Sibanda, T. and Okeh,A. (2012). Seroprevalence of Hepatitis B Surface Antigenemia and its Effects on Haematological Parameters in Pregnant Women in Osogbo, Nigeria. Virology Journal, 9,317.
Utoo, B.T. (2013). Hepatitis B surface Antigenemia (HBsAg) Among Pregnant Women in Southern Nigeria. African Health Science,13(4), 1139-1143.
Eze, M.E., Buseri, F.I., Wachukwu, C.K. and Nnatuanya, I.N. (2008). Effects of Hepatitis B Infection on Haematological Parameters in Pregnancy in Port-Harcourt, Nigeria. Research Journal of Medical Sciences, 3(6), 194-197.
Dongdem, J.T., Sylvanus, K., Ireneous, N.S., Patric, N.A., Juventus, B.Z. and Kenneth, S. (2012). Prevalence of Hepatitis B Virus Infection Among Blood Donors at the Tamale Teaching Hospital Ghana. (2009). BMC Research Notes, 5(1)115.
Uneke, C.J., Ogbu, O., Inyama, P.U., Anyanwu, G.I., Njoku, M.O. and Idoka, J.H. (2005). Prevalence of Hepatitis B Surface Antigen among Blood Donors and Human Immunodeficiency Virus-Infected Patients in Jos, Nigeria, 100 (1), 13-16.
American Association of Blood Banks (AABB) (2005): Standards For Bloo0d Banks and Transfusion Services. 23rd edition. Bethesda, USA. 22- 34.
Mast, E.E., Wembaum., C.M. and Flore, A . E . ( 2 0 0 6 ) . A C o m p r e h e n s i v e Immunization Strategy to Eliminate Transmission of Hepatitis-B Virus Infection in the United States: Recommendation of the Advisory Committee on Immunization Practices (ACIP) Part 11: Immunization of Adults, 55, 1-33.
Aba, H.O. and Aminu, M. (2016). Seroprevalence of Hepatitis- B. Virus Serological Markers among pregnant Nigerian Women. Annals of African Medicine, 15, 20-27.
Uchida, Y., Imamura, M., Hayes, N.C., Hiraga, N. and Chayama, K. (2017). Persistent Loss of Hepatitis-B Virus Markers in Serum Without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in humanized mice Antimicrobial Agents Chemotherapy, 61, 725-738.
Belo,A. C.(2000). Prevalence of Hepatitis-B markers in surgeons in Lagos, Nigeria. East African Medical Journal, 77(5), 283 – 285.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Nigerian Journal of Parasitology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
